TCR-T Cells for the Treatment NY-ESO-1-positive Advanced Solid Tumors
Clinical trial NCT05648994 · UNKNOWN
Trial details
- NCT number
- NCT05648994
- Sponsor
- Fujian Cancer Hospital
- Status
- UNKNOWN
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-12-01
- Primary completion
- 2024-02-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.